The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A comprehensive analysis of molecular profiles across over 10,000 tumor and germ-line exomes across more than 20 tumor types: Novel mechanisms and targets for clinical treatment.
Shahrooz Rabizadeh
Employment or Leadership Position - NantOmics
Stock Ownership - NantOmics
Research Funding - NantOmics
Stephen Charles Benz
Employment or Leadership Position - Five3 Genomics
Stock Ownership - Five3 Genomics
Research Funding - NantOmics
John Z Sanborn
Employment or Leadership Position - Five3 Genomics
Stock Ownership - Five3 Genomics
Research Funding - NantOmics
Charles Joseph Vaske
Employment or Leadership Position - Five3 Genomics
Stock Ownership - Five3 Genomics
Research Funding - NantOmics
Patrick Soon-Shiong
Employment or Leadership Position - NantOmics
Stock Ownership - NantOmics
Research Funding - NantOmics